Effect of pre-treatment with catecholamines on cold preservation and ischemia/reperfusion-injury in rats

Kidney International

Volumn 70, Issue 2, 2006, Pages 321-328

  Gottmann, U ^a   Brinkkoetter, P T ^a   Bechtler, M ^a   Hoeger, S ^a   Karle, C ^a   Schaub, M ^a   Schnuelle, P ^a   Yard, B ^a   Van Der Woude, F J ^a   Braun, C ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

Author keywords

Catecholamines; Cold preservation; Ischemia reperfusion; Kidney; Rat; Transplantation

Indexed keywords

CATECHOLAMINE; DOBUTAMINE; DOPAMINE; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; PROTEIN P42; PROTEIN P44; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL INFILTRATION; CLIP; CRYOPRESERVATION; ENDOTHELIUM CELL; HISTOCOMPATIBILITY COMPLEX; ISCHEMIA; ISOGRAFT; KIDNEY; KIDNEY FUNCTION; MALE; MONONUCLEAR CELL; NEPHRECTOMY; NEPHRITIS; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UPREGULATION;

ANIMALS; CATECHOLAMINES; COLD; CRYOPRESERVATION; DOBUTAMINE; DOPAMINE; DOPAMINE AGENTS; GRAFT SURVIVAL; ISCHEMIC PRECONDITIONING; KIDNEY; KIDNEY TRANSPLANTATION; MALE; NEPHRECTOMY; NOREPINEPHRINE; RATS; RATS, INBRED LEW; REPERFUSION INJURY; SYMPATHOMIMETICS;

EID: 33746318931     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001501     Document Type: Article

References (51)

1. Terasaki PI, Cecka JM, Gjertson DW et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-336.
2. Gjertson DW. A multi-factor analysis of kidney regraft outcomes. Clin Transplant 2002: 335-349.
3. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 1996; 155: 1831-1840.
4. McLaren AJ, Jassem W, Gray DW et al. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999; 13: 266-272.
5. Goes N, Urmson J, Ramassar V et al. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59: 565-572.
6. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045.
7. Schnuelle P, Lorenz D, Mueller A et al. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation. Kidney Int 1999; 56: 738-746.
8. Schnuelle P, Berger S, de Boer J et al. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001; 72: 455-463.
9. Schaub M, Ploetz CJ, Gerbaulet D et al. Effect of dopamine on inflammatory status in kidneys of brain-dead rats. Transplantation 2004; 77: 1333-1340.
10. Yard B, Beck G, Schnuelle P et al. Prevention of cold-preservation injury of cultured endothelial cells by catecholamines and related compounds. Am J Transplant 2004; 4: 22-30.
11. Kellum JA, J MD. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001; 29: 1526-1531.
12. Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest 2003; 123: 1266-1275.
13. Bellomo R, Giantomasso DD. Noradrenaline and the kidney: friends or foes? Crit Care 2001; 5: 294-298.
14. Andorn AC, Pappolla MA. Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain. Free Radic Biol Med 2001; 31: 315-320.
15. Miura T, Muraoka S, Ogiso T. Antioxidant activity of adrenergic agents derived from catechol. Biochem Pharmacol 1998; 55: 2001-2006.
16. Ondrias K, Stasko A, Gergel D et al. Antioxidant and pro-oxidant effects of epinephrine and isoprenaline on peroxidation of LDL and lipid liposomes. Physiol Res 1998; 47: 119-124.
17. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996; 20: 933-956.
18. Kang MY, Tsuchiya M, Packer L et al. In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand 1998; 42: 4-12.
19. Berger SP, Hunger M, Yard BA et al. Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro. Kidney Int 2000; 58: 2314-2319.
20. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001; 276: 11870-11876.
21. Park KM, Kramers C, Vayssier-Taussat M et al. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 2002; 277: 2040-2049.
22. Yue T-L, Wang C, Gu J-L et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000; 86: 692-699.
23. Kunduzova OR, Bianchi P, Pizzinat N et al. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J 2002; 16: 1129-1131.
24. 2 produced by monoamine oxidase. Kidney Int 2001; 59: 76-86.
25. Narkar V, Kunduzova O, Hussain T et al. Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney. Kidney Int 2004; 66: 633-640.
26. Narkar VA, Hussain T, Pedemonte C et al. Dopamine D(2) receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J Am Soc Nephrol 2001; 12: 1844-1852.
27. Bonventre JV. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J Am Soc Nephrol 2003; 14(Suppl 1): S55-S61.
28. Ping P, Zhang J, Huang S et al. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. Am J Physiol 1999; 277: H1771-H1785.
29. Xu Z, Ji X, Boysen PG. Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. Am J Physiol Heart Circ Physiol 2004; 286: H1433-H1440.
30. Yang XM, Krieg T, Cui L et al. NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. J Mol Cell Cardiol 2004; 36: 411-421.
31. di Mari JF, Davis R, Safirstein RL. MAPK activation determines renal epithelial cell survival during oxidative injury. Am J Physiol 1999; 277: F195-203.
32. Ishizuka S, Yano T, Hagiwara K et al. Extracellular signal-regulated kinase mediates renal regeneration in rats with myoglobinuric acute renal injury. Biochem Biophys Res Commun 1999; 254: 88-92.
33. Arany I, Megyesi JK, Reusch JE et al. CREB mediates ERK-induced survival of mouse renal tubular cells after oxidant stress. Kidney Int 2005; 68: 1573-1582.
34. Sarkar DK, Chaturvedi K, Oomizu S et al. Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes. Endocrinology 2005; 146: 4179-4188.
35. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641.
36. Nowak G, Schnellmann RG. Autocrine production and TGF-beta 1-mediated effects on metabolism and viability in renal cells. Am J Physiol 1996; 271: F689-697.
37. Humes HD, Cieslinski DA. Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture. Exp Cell Res 1996; 201: 8-15x.
38. Basile DP, Rovak JM, Martin DR et al. Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol 1996; 270: F500-F509.
39. Gobe G, Zhang XJ, Willgoss DA et al. Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 2000; 11: 454-467.
40. Basile DP, Martin DR, Hammerman MR. Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-beta in repair. Am J Physiol 1998; 275: F894-F903.
41. Lacha J, Hribova P, Kotsch K et al. Effect of cytokines and chemokines (TGF-beta, TNF-alpha, IL-6, IL-10, MCP-1, RANTES) gene polymorphisms in kidney recipients on posttransplantation outcome: influence of donor-recipient match. Transplant Proc 2005; 37: 764-766.
42. Spurgeon KR, Donohoe DL, Basile DP. Transforming growth factor-beta in acute renal failure: receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury. Am J Physiol Renal Physiol 2005; 288: F568-F577.
43. Schnuelle P, Yard BA, Braun C et al. Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant 2004; 4: 419-426.
44. Tremblay J, Chen H, Peng J et al. Renal ischemia-reperfusion injury in the rat is prevented by a novel immune modulation therapy. Transplantation 2002; 74: 1425-1433.
45. Chatterjee PK, Zacharowski K, Cuzzocrea S et al. Lipoteichoic acid from Staphylococcus aureus reduces renal ischemia/reperfusion injury. Kidney Int 2002; 62: 1249-1263.
46. Yang CW, Ahn HJ, Han HJ et al. Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation 2001; 72: 1753-1759.
47. Wagner M, Cadetg P, Ruf R et al. Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. Kidney Int 2003; 63: 1564-1573.
48. Tullius SG, Nieminen-Kelha M, Buelow R et al. Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1. Transplantation 2002; 74: 591-598.
49. Land W, Schneeberger H, Schleibner S et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211-217.
50. Gottmann U, Notheisen A, Brinkkoetter PT et al. Influence of donor pretreatment with dopamine on allogeneic kidney transplantation after prolonged cold storage in rats. Transplantation 2005; 79: 1344-1350.
51. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-421.